In February 2025, apart from a few vitamin prices experiencing changes, the prices of other vitamins all fluctuated normally. Vitamin B3 began a continuous price decline in October 2024. However, due to the impact of an incident at an Indian factory, its price turned from falling to rising this month, showing a price recovery.
On 8 Feb., 2025, the new version of the "National Food Safety Standard—Use of Food Additives" (GB 2760—2024) was officially implemented, replacing the 2014 version that had been in use for 10 years.
As of the end of January 2025, nine vitamin-listed companies had released their performance forecasts for 2024, which showed that many companies expected an increase in net profit.
Project Progress of Many Companies
- Anhui Fengyuan Pharmaceutical Co., Ltd., Wuhu Pharmaceutical Factory: Completion of environmental protection acceptance for Vitamin C chewable tablets and Vitamin C effervescent tablets projects;
- Anhui XinHong Pharmaceutical Co., Ltd.: Approval of the first phase of the cholesterol expansion project;
- HTBA: Investment in upgrading a factory to produce the active form of Vitamin B12;
- Shandong New Element Bio: Completion of environmental protection acceptance for the first phase of the investment expansion project for natural Vitamin E and other food additives.
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1693 on 5 Feb., 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
- New version for food additives use officially implemented
- Nine vitamin-related listed companies release performance forecasts for 2024
- Anhui Fengyuan Pharma's vitamin C project passes phased acceptance check
- DSM-Firmenich sells its shares in Feed Enzymes Alliance
- EI report of Anhui Xinhong Pharm's cholesterol project (Phase I) approved
- DSM-Firmenich realeases full-year and Q4 financial results for 2024
- HTBA invests in Vitamin B12 plant upgrade
- Shandong New Elemental's vitamin E project (Phase I) passes acceptance check
- Ex-works prices of selected vitamins in China, Feb. 2025
- Price of vitamin B3 rebounds in February
- Imports and exports of vitamins in China
- Two companies obtained FAMI-QS certifications
- Haotian Pharm's inositol and baicalin recognized as patent-intensive products
- Yuanqi Forest launched new Vitamin B water
- Wanhua Chemical invests in citral chain tech upgrade
- Keluoyi Pharma vitamin B series product project approved
- Guanrun Pharma's nicotinamide renovation project passes acceptance check
- Beisha Pharma's trimethylhydroquinone project passes acceptance check
- Shangru Hongyi Fine Chemical proposes 70 t/a Vitamin K3 pilot project
- Guangji Pharma's vitamin production system upgrade project
- Tianxin Pharma's 3,500 t/a vitamin A project


